ANNALS OF THE RHEUMATIC DISEASES, vol.76, no.4, 2017 (SCI-Expanded)
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) clinical trials that represent both patients' and physicians' priorities.